EL
Insider buying
Evan Lockwood Rachlin bought $11.5M of IAM stock
Evan Lockwood Rachlin, Dir of Iambic Therapeutics, Inc. (IAM), bought 718,750 shares of IAM stock worth $11.5M, per an SEC Form 4 filed Oct 19, 2026.
It was an open-market purchase.
The trade happened on Oct 16, 2026, 3 days before it was made public.
- Traded
- Oct 16, 2026
- Disclosed
- Oct 19, 2026
- Filing delay
- 3 days
- Role
- Dir
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.